GoT-Multi maps somatic genotypes and transcriptomes in single cancer cells, revealing more on clonal evolution and therapy resistance.

Scalable, workflow-optimized solutions will be essential to improving cancer care in emerging and previously underserved ...

Despite economic uncertainty, the CEOs of life science and biotech companies are making artificial intelligence a top ...

A year after his Nobel Prize win, David Baker highlights AI in protein design at Seattle's latest fundraiser to support STEM PhD students.

Novo Nordisk saw a competitor’s bet and raised the stakes in metabolic dysfunction-associated steatohepatitis (MASH) with its planned up-to-$5.2 billion acquisition of Akero Therapeutics.

Programmable proteins designed with Boolean logic gates may improve targeted drug delivery precision and scalability, ...

During GEN's State of Biotech virtual summit, George Church, PhD, shared his thoughts on genomics and much, much more.

Raubling, Germany-based Axplora, which focuses on small-molecule API manufacturing reports that its total investments ...

Universities must do more to provide students with cell and gene therapy manufacturing skills, according to a new study.

This week's episode features two Nobel Prize announcements, a potential gene therapy for Huntington’s, and a partnership to develop gene editing therapies for rare diseases.

The largest genetic map of human metabolism reveals new insights on the role of metabolites in health and disease.

The super adjuvant vaccine also protected against the spread of cancer to the lungs. When exposed to melanoma cells systemically, which mimics how cancer metastasizes, none of the ...